• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 382544
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/29/2017
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown. The date received by manufacturer has been used for this field. There were multiple lot numbers reported to be involved. The information for each lot number is as follows: medical device lot #: 7027704. Medical device expiration date: 2019-12-31. Device manufacture date: 2017-01-27. Medical device lot #: 6119804. Medical device expiration date: 2019-04-30. Device manufacture date: 2016-04-28. Investigation summary: device/batch history record review: review of dhr revealed all required challenge samples and testing was conducted per specifications and in accordance with the in-process sampling plans. Review disclosed no reject activity findings throughout the build of this lot that would impact the outcome of the quality of the product relevant to the defect stated in the pir. Received two unused 18ga bd insyte autoguard blood control catheter unit within a partially opened packages. One from lot 7027704 one from lot 6119804. All components were present and intact. Visual/microscopic examination: lot 702774: observed that although the unit package had a partially open seal at the top of the blister pack; the unit package (blister pack) demonstrated to have had an adequate seal with no anomalies at time of manufacturing. Lot 6119804: observed that although the unit package had a partially open seal at the top and bottom of the blister pack; the unit package (blister pack) demonstrated to have had an adequate seal with no anomalies at time of manufacturing. The package had a tear of the top web (label) at the top of the package. Package leak test; was not conducted as the package seal integrity was breached. Note: the product characteristics require a minimum of 1/8¿ seal transfer. This characteristic was met. In addition the paper top web of the returned units was analyzed under uv light. The glue used to seal the top and bottom webs is uv fluorescent. The analysis revealed adequate top web adhesive. The key variables that affect seal strength are: seal transfer/width and top web glue. Both of these variables were included in the investigation. Although the packages were partially opened at the top and/or bottom; the units (blister packs) received and evaluated for this incident was acceptable per the manufacturing specification requirements of the unit package. Investigation conclusion: confirmation of the defect of package seal integrity poor / questionable, as stated in the pr was conclusive with the units provided for this incident; as the units were received with partially opened packaging (blister packs). Although the packages were received partially opened at the top and/or bottom, all the process characteristics that directly influence the seal strength are: seal transfer and top web glue, measured within specification. No anomalies were found and all the process characteristics that directly influence the seal strength (seal transfer and top web glue) were met. Confirmed the units were acceptable per specification requirements. The failure of package seal integrity poor / questionable that the customer experienced was confirmed. It was not necessary to achieve reproduction of the customer¿s experience of package seal integrity poor / questionable, as the defect was confirmed. Root cause description: although the packages were received partially opened; there was no physical evidence to confirm or to support manufacturing process related issues for the defect. In addition, packaging operators are responsible to verify the seal transfer/width and that packages are ¿water leak tested¿ every hour. These attribute inspections are done to verify that the packages are sealed adequately prior to placing them within the dispenser. This is issue is currently being investigated by capa (b)(4).
 
Event Description
It was reported that the packages of bd insyte¿ autoguard¿ bc shielded iv catheter were not sealed before use. No injury or medical intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameBD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
Type of DeviceINTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652845
MDR Report Key7131901
MDR Text Key95736373
Report Number1710034-2017-00471
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903825449
UDI-Public30382903825449
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Reporter Occupation
Type of Report Initial
Report Date 12/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number382544
Device Lot NumberSEE H.10.
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/06/2017
Is the Reporter a Health Professional? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received11/29/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 12/19/2017 Patient Sequence Number: 1
-
-